GC Corp. - Jul 18, 2024 Form 3 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role: 10%+ Owner
Signature: GC Corp By: /s/ Yong-Jun Huh, Chief Executive Officer
Stock symbol: ARTV
Transactions as of: Jul 18, 2024
Transactions value $: $0
Form type: 3
Date filed: 7/18/2024, 08:05 PM
Next filing: Jul 22, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ARTV	Common Stock						349K	Jul 18, 2024	Direct	F1
holding	ARTV	Common Stock						233K	Jul 18, 2024	By GC Cell Corporation	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ARTV	Series A Preferred Stock							Jul 18, 2024	Common Stock	667K		Direct	F1, F3
holding	ARTV	Series B Preferred Stock							Jul 18, 2024	Common Stock	330K		Direct	F1, F3
holding	ARTV	Series A Preferred Stock							Jul 18, 2024	Common Stock	293K		By GC Cell Corporation	F2, F3
holding	ARTV	Series B Preferred Stock							Jul 18, 2024	Common Stock	62.2K		By GC Cell Corporation	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	GC Corp., a public Korean holdings company, is ultimately controlled by its board of directors, consisting of Mr. Yong-Jun Huh, Huh II-Sup, Park Yong-Tae and Kim Seok-Hwa. Each of these individual directors of GC Corp. may be deemed to share voting and investment power over the shares held by GC Corp. and each disclaims beneficial ownership of all shares held by CG Corp., except to the extent of any pecuniary interest therein.
F2	The shares are held directly by GC Cell Corporation. GC Corp., a public Korean holdings company, is the parent company of GC Cell Corporation and is ultimately controlled by its board of directors, consisting of Mr. Yong-Jun Huh, Huh II-Sup, Park Yong-Tae and Kim Seok-Hwa. Each of these individual directors of GC Corp. may be deemed to share voting and investment power over the shares held by GC Corp. and GC Cell Corporation and each disclaims beneficial ownership of all shares held by such entities, except to the extent of any pecuniary interest therein.
F3	Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") is convertible into shares of Common Stock of the Issuer on a one-for-one basis without payment of further consideration. Upon the closing of the Issuer's initial public offering, the Preferred Stock will convert into the number of shares of Common Stock of the Issuer shown in column 3. The Preferred Stock has no expiration date.